OPTICAL COHERENCE TOMOGRAPHY for the assessment of the need for treatment following provision of pharmaceutical benefits scheme-subsidised ocriplasmin. Maximum of one service per eye per lifetime.
OPTICAL COHERENCE TOMOGRAPHY for the assessment of the need for treatment following provision of pharmaceutical benefits scheme-subsidised ocriplasmin. Maximum of one service per eye per lifetime.
| Release | Change | Old | New |
|---|---|---|---|
| July 2026 | Fee ↑ | $46.6 | $47.8 |
Data sourced from Australian Government publications · Not an official government service